06 jun: Europa/aktier: ECB-meldinger overskygget af positiv stemning
07 jun: USA/aktier: Håb om stimuli giver største stigning i 2012
06-06-2012 20:51:00

CORRECT: Ahold Suffers From Price Competition in 1Q

("Ahold Suffers From Price Competition in 1Q," at 1:35 a.m. EDT, misstated the Food Lion brand was unprofitable in the 10th paragraph, and in an update at 4:58 a.m. EDT. The correct version follows:)

By Robert van den Oever

AMSTERDAM--Retailer Royal Ahold NV (AH.AE), which runs the Stop & Shop and Giant supermarket chains in the U.S., Wednesday posted a slight fall in first-quarter net profit as intense price competition weighed on margins.

Ahold expects 2012 to be challenging, with price competition continuing and consumer spending under pressure, said Chief Executive Dick Boer, although he added that he's encouraged by the improving sales trend in the second quarter.

The company is outperforming Belgian rival Delhaize Group (DELB.BT) in the U.S., even though its flagship chains have faced fierce competition as retailers battled to lure increasingly price-sensitive customers. Delhaize makes more than half of its sales in the U.S., but Ahold gained market share there during the first quarter with increased promotional activity.

In the Netherlands, which accounts for a third of Ahold's sales, the retailer is suffering from low consumer confidence as shoppers grapple with the government's austerity measures, although it managed to maintain its market share. Its core chain, Albert Heijn, has around 33% market share, which will grow due to the recent acquisition of 82 stores from competitor Jumbo.

In the three months to March 31, Ahold's net profit fell 3.1% to EUR282 million from EUR291 million a year earlier. Analysts had forecast a rise to EUR305 million, according to FactSet.

Net sales totaled EUR9.71 billion, up 5% from a year earlier, short of analysts' expectations for EUR9.81 billion. Sales growth was a healthy 2.8% in the U.S. and a modest 1.2% in the Netherlands.

Underlying margin dropped to 4.3% from 4.6% and operating result was down 6.3% to EUR416 million.

Ahold said it is on target to deliver EUR350 million in cost savings for the next three years.

In the coming quarters, Ahold's sales and profit will benefit from the consolidation of its recent acquisitions: online retailer Bol.com and 82 stores in the Netherlands from Jumbo.

Delhaize last month swung to a first-quarter net loss, which it attributed to charges related to store closures in the U.S. under its Food Lion brand, as well as openings under its discount Bottom Dollar chain. Its volumes have taken a tumble after it raised prices at Food Lion in an effort to pass on cost inflation to customers, but improved in the first quarter from the fourth quarter of 2011. The Belgian company said underlying operating profit is this year expected to decrease by 15% to 20% at identical exchange rates compared with 2011--far below market expectations.

Ahold is in the process of putting its EUR2.6-billion cash pile to better use, with a focus on organic growth and bolt-on acquisitions. The acquisition of Bol.com, announced in February and completed in May, was an important step. It also aims to open a fifth store in Belgium, aiming for 10 by the end of 2012 and 50 in the next five years. It will open its first German store in the third quarter.

Ahold's shares closed at EUR9.59 on Tuesday, valuing the company at EUR10.5 billion.

Write to Robert van den Oever at robert.vandenoever@dowjones.com

(END) Dow Jones Newswires

June 06, 2012 14:51 ET (18:51 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
22 jul
BAVA
Er der rigtigt forstået, at vi venter på at flere i forsøget skal dø før vi kan se på resultatet?   ..
51
21 jul
FING-B
Du er overalt. Du skriver i Fingersprint trådene og opretter derefter ny tråd med samme indhold. Nu ..
45
19 jul
GEN
Ja, det ligner simpelthen ingenting. Siden starten af 2012 er Genmab under ledelse af Jan W. kun ste..
24
23 jul
BAVA
Spændende og meget relevante spørgsmål Pits.   Vi har indtil nu nået de første to analysetidspunkte..
23
22 jul
NOVO-B
Stærk analyse.  
13
23 jul
BAVA
Gode spørgsmål!   Ja, der er en klar sammenhæng mellem tilvalg/fravalg af behandling indenfor prosta..
12
19 jul
PNDORA
Alle disse Pandora tråde uden substans lugter langt væk af desperation.
12
20 jul
 
Et kæmpe tab. En sindsyg dygtig, højt respekteret og solid klippe af "sund fornuft" som igennem mang..
11
18 jul
VELO
  Den kinesiske pendant til amerikanske FDA, er i foråret 2017 begyndt og tilbyder forhåndsgodkendel..
11
22 jul
VWS
Bid mærke i, at nu er selv energikæmpen GE mere grøn end sort: http://www.business.dk/energi/groen-e..
10

Aktier/middag: Novo og Genmab presser dansk marked i rødt

24-07-2017 11:27:49
Det danske aktiemarked er præget af kursfald mandag, hvor Novo Nordisk, Genmab og Pandora er under størst pres blandt de største aktier.Omkring middagstid falder C20 Cap-indekset 0,8 pct. til 1159,07. Det er primært en svækkelse af dollar og justeringer af kursmål, som er i fokus, inden den danske regnskabssæson for alvor kommer op i gear i starten af august.- Dollar er blevet svækket på det senes..

Carlsberg/Berenberg: Kursmålet løftes til 652 kr. - gentager "hold"

24-07-2017 08:13:02
Carlsberg gør sig fortsat kun fortjent til anbefalingen "hold" hos den tyske bank Berenberg, der dog sætter et nyt kursmål på 652 kr. mod tidligere 577 kr.Det sker i en dugfrisk brancheanalyse, hvor bankens bryggerianalytikere har set nærmere på det vietnamesiske marked.Berenberg fastholder i analysen også anbefalingen "hold" af Heineken, mens Anheuser-Busch Inbev stadig foretrækkes med anbefaling..

Vestas-rival får vindmølleordre til projekt i Indonesien i hus

21-07-2017 16:09:14
Tysk-spanske Siemens Gamesa har landet en ordre på 72 megawatt (MW) fordelt over 20 vindmøller af typen SWT-3,6-130 til et projekt i Indonesien.Projektet, som hedder Tolo 1, bliver udviklet af det lokale energiselskab Equis Energy, der også står som køber af møllerne. De skal efter planen installeres mod slutningen af 2017, hvorefter idriftsættelse kan indledes tidligt i 2018. Sammen med ordren ha..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/middag: Novo og Genmab presser dansk marked i rødt
2
Genmab/Carnegie: Mere end fordobler kursmål og sænker anbefaling
3
Mandagens aktier: Novo og Novozymes faldt mest i presset marked
4
Aktier/tendens: Analytikerne ser med mildere øjne på Carlsberg og GN
5
Volkswagen holder ekstraordinært møde under kartelmistanke

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. juli 2017 06:37:59
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170720.2 - EUROWEB6 - 2017-07-25 06:37:59 - 2017-07-25 06:37:59 - 1 - Website: OKAY